Nina Niu Sanford: A balanced editorial of MR-guided RT

JAMA Oncology shared a post on X, about recent paper published in JAMA Oncology:

MRI-Linac–Based Radiotherapy—Promising or Hype?

Authors: Mack Roach, Stella Ling, Pamela W. Coleman.

”Viewpoint discusses the value of magnetic resonance imaging with linear accelerator (MRI-linac) technology, given the unmet needs in its development.”

Nina Niu Sanford shared JAMA Oncology’s post on X, adding:

”This is a balanced editorial of MR-guided RT.

Like any other RT technology, there is both promise and hype.

I think we all recognize scenarios where we think MR is very helpful, but can also acknowledge that current policies permit its use for cases with likely 0 clinical benefit.”

Source: JAMA Oncology/X and Nina Niu Sanford/X

Nina Niu Sanford is an Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital. She specializes in treating gastrointestinal cancers and actively participates in clinical trials combining high-dose radiation therapy with immunotherapy. Additionally, she researches healthcare access disparities and conducts pan-cancer outcomes research using large databases.